AKBA
AKBA
NASDAQ · Biotechnology

Akebia Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.91
-0.04 (-4.66%)
As of Aug 8, 10:25 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +4,015.8% upside
Low Target $22.27
Average Target $37.45
High Target $46.32
Current Price $0.91
Current
$0.91
Target
$37.45
$22.27 $37.45 avg $46.32
Scenario Analysis
Bear Case
$22.27
2,347.5%
Low target
Base Case
$37.45
+4,015.8%
Avg target
Bull Case
$46.32
+4,990.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.79
-76.0% from high
52-Week Low
$0.82
+10.6% from low
50-Day SMA
$1.26
-27.8% vs SMA
RSI (14)
38.1
Neutral
Target vs 52W High
$37.45
+888.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%